A bold call from Wall Street has put fresh attention on a fast-growing (and still speculative) artificial intelligence (AI) infrastructure play.

Cloud revenue accelerates in Q1 FY2026, AI infrastructure demand lifts remaining performance obligations, OpenAI contract ...

Revenue (GAAP) rose sharply to $2.7 million for Q2 2025, driven primarily by a one-time recognition of deferred revenue from a terminated legacy agreement. Net loss (GAAP) narrowed dramatically year ...

Cognyte Software Ltd. (NASDAQ:CGNT) posted second-quarter revenue that surpassed analyst expectations and raised its full-year guidance, driven by strong demand for its AI-powered investigative ...

Arbutus Biopharma is a clinical-stage biotechnology company developing therapies targeting chronic hepatitis B virus (cHBV) and leveraging lipid nanoparticle (LNP) delivery technology. Its leading ...

GAAP revenue of $19.1 million in Q2 2025 exceeded consensus by 49.6%, driven by recognition of partnership milestone payments. R&D expenses declined 28.4%, while SG&A rose 65.5%, both on a GAAP basis ...